SMTL ID : 6md8.1 (1 other biounit)

Crystal structure of CTX-M-14 with compound 3

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.40 Å

Oligo State

monomer

Ligands

2 x J84: 1-(2,4-dichlorophenyl)-4-(1H-tetrazol-5-yl)-1H-pyrazol-5-amine(Non-covalent)

J84.1: 9 residues within 4Å: Chain A: S.45, N.79, Y.80, S.105, N.107, T.210, G.211, S.212 Ligands: DMS.3 8 PLIP interactions: 8 interactions with chain A Hydrogen bonds: A:S.45, A:S.105, A:N.107, A:K.209, A:S.212, A:S.212 Water bridges: A:S.212, A:S.212 J84.2: 9 residues within 4Å: Chain A: Q.1, T.2, L.24, T.31, Q.32, V.33, I.259, G.262, L.263 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:Q.1, A:L.24, A:T.31, A:L.263 Hydrogen bonds: A:Q.32, A:Q.32 Halogen bonds: A:Q.1, A:I.259

1 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)

DMS.3: 4 residues within 4Å: Chain A: Y.80, S.105, T.191 Ligands: J84.1 No protein-ligand interaction detected (PLIP)

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Torelli, N.J. et al., Active-Site Druggability of Carbapenemases and Broad-Spectrum Inhibitor Discovery. Acs Infect Dis. (2019)

Release Date

2019-04-17

Peptides

Beta-lactamase CTX-M-14: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Beta-lactamase CTX-M-14

Related Entries With Identical Sequence